Skip to main content
Premium Trial:

Request an Annual Quote

NCI Names Moxie Informatics as Latest caBIG Support Service Provider

Premium

The National Cancer Institute said this week that it has licensed Moxie Informatics to provide services as part of the Cancer Biomedical Informatics Grid's Support Service Providers Program.

Under the program, NCI provides licenses to entities who meet specific criteria for performing informatics support services related to caBIG. NCI has issued support service licenses to 16 commercial firms and one university since the program began in October 2008.

Moxie was granted a license to adapt and enhance caBIG -compatible software applications, one of four categories of support under the program. The other support areas include help desk support; deployment support for caBIG software applications; and documentation and training materials and services.

A fifth service category, data sharing and security framework implementation support, was included in the most recent application round for the service provider program, which was posted in January.

Rockville, Md.-based Moxie was founded in 2008 by Sashi Thangaraj, who previously served at caBIG contractor SAIC, where he worked on several caBIG development projects. The company was founded with the intention of providing software and IT infrastructure development services, with a particular focus on the open-source caLIMS2 software [BioInform 8-20-2009].

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.